Active, not recruiting
Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
NCT04650581
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Southern Highlands Cancer Centre Bowral, New South Wales, Australia
- Lake Macquarie Private Hospital Gateshead, New South Wales, Australia
- Gosford Hospital Gosford, New South Wales, Australia
- Macquarie University Hospital Macquarie University, New South Wales, Australia